NIH researchers identify brain connections associated with ADHD in youth
Researchers at the National Institutes of Health (NIH) have discovered that symptoms of attention-deficit/hyperactivity disorder (ADHD) are tied to atypical interactions between the brain’s frontal cortex and information processing centers…
NIH opens long COVID trials to evaluate treatments for autonomic nervous system dysfunction
Two phase 2 clinical trials to test the safety and effectiveness of three treatments for adults with autonomic nervous system dysfunction from long COVID have begun. The autonomic nervous system…
Semaglutide Reduces Severity of Common Liver Disease in People with HIV #CROI2024
A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according…
Tools underestimate cardiovascular event risk in people with HIV #CROI2024
The elevated cardiovascular disease risk among people with HIV is even greater than predicted by a standard risk calculator in several groups, including Black people and cisgender women, according to…
CDC updates and simplifies respiratory virus recommendations
CDC released today updated recommendations for how people can protect themselves and their communities from respiratory viruses, including COVID-19. The new guidance brings a unified approach to addressing risks from…
Smoking cannabis associated with increased risk of heart attack, stroke
Frequent cannabis smoking may significantly increase a person’s risk for heart attack and stroke, according to an observational study supported by the National Institutes of Health. The study, published in…
Antibody reduces allergic reactions to multiple foods in NIH clinical trial
A 16-week course of a monoclonal antibody, omalizumab, increased the amount of peanut, tree nuts, egg, milk and wheat that multi-food allergic children as young as 1 year could consume…
Moderately to everely active Ulcerative Colitis, European Commission approves Pfizer’s etrasimod (Velsipity®)
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has granted marketing authorization for VELSIPITY® (etrasimod) in the European Union to treat patients 16 years of age and…
Researchers optimize genetic tests for diverse populations to tackle health disparities
To prevent an emerging genomic technology from contributing to health disparities, a scientific team funded by the National Institutes of Health has devised new ways to improve a genetic testing…
Switching to vegan or ketogenic diet rapidly impacts immune system
Researchers at the National Institutes of Health observed rapid and distinct immune system changes in a small study of people who switched to a vegan or a ketogenic (also called…